Gene editing in tree and clonal crops: progress and challenges

被引:15
|
作者
Goralogia, Greg S. [1 ]
Redick, Thomas P. [2 ]
Strauss, Steven H. [1 ]
机构
[1] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA
[2] Global Environm Eth Counsel GEEC LLC, 65 Arundel Pl, Clayton, MO 63105 USA
关键词
Genome editing; Forest Biotechnology; Clonal propagation; SITE-SPECIFIC RECOMBINATION; T-DNA TRANSFER; TRANSGENIC PLANTS; MARKER-FREE; PROANTHOCYANIDIN BIOSYNTHESIS; TARGETED MUTAGENESIS; FLP RECOMBINASE; GUAIACYL LIGNIN; TRANSFORMATION; SUSCEPTIBILITY;
D O I
10.1007/s11627-021-10197-x
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Because of the limitations inherent in conventional breeding of trees and clonally propagated crops, gene editing is of great interest. Dozens of published papers attest to the high efficiency of CRISPR-based systems in clonal crops and trees. The opportunity for "clean" edits is expected to avoid or reduce regulatory burdens in many countries and may improve market acceptance. To date, however, nearly all studies in trees and clonal crops retained all of the gene editing machinery in the genome. Despite high gene editing efficiency, technical and regulatory obstacles are likely to greatly limit progress toward commercial use. Technical obstacles include difficult and slow transformation and regeneration, delayed onset of flowering or clonal systems that make sexual segregation of CRISPR-associated genes difficult, inefficient excision systems to enable removal of functional (protein- or RNA-encoding) transgenic DNA, and narrow host range or limited gene-payload viral systems for efficient transient editing. Regulatory obstacles include those such as in the EU where gene-edited plants are regulated like GMO crops, and the many forms of method-based systems that regulate stringently based on the method vs. product novelty and thus are largely applied to each insertion event. Other major obstacles include the provisions of the Cartagena Protocol with respect to international trade and the need for compliance with the National Environmental Policy Act in the USA. The USDA SECURE act has taken a major step toward a more science- and risk-based-vs. method and insertion event based-system, but much further regulatory and legal innovation is needed in the USA and beyond.
引用
收藏
页码:683 / 699
页数:17
相关论文
共 50 条
  • [21] Genome editing: progress and challenges for medical applications
    Dana Carroll
    Genome Medicine, 8
  • [22] Genome editing: progress and challenges for medical applications
    Carroll, Dana
    GENOME MEDICINE, 2016, 8
  • [23] Research progress in gene editing technology
    Huang, Sheng
    Yan, Yali
    Su, Fei
    Huang, Xiaorui
    Xia, Dandan
    Jiang, Xinxin
    Dong, Yinghui
    Lv, Ping
    Chen, Fangyuan
    Lv, Yanwei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (10): : 916 - 927
  • [24] Opportunities, Challenges, and Scientific Progress in Hemp Crops
    Kaminski, Kacper Piotr
    Hoeng, Julia
    Goffman, Fernando
    Schlage, Walter K.
    Latino, Diogo
    MOLECULES, 2024, 29 (10):
  • [25] Challenges of Gene Editing Therapies for Genodermatoses
    Brooks, Imogen R.
    Sheriff, Adam
    Moran, Declan
    Wang, Jingbo
    Jackow, Joanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [26] Challenges to Gene Editing Approaches in the Retina
    Bonillo, Mario
    Pfromm, Julia
    Fischer, M. Dominik
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (03) : 275 - 283
  • [27] Gene editing poses challenges for journals
    Cressey, Daniel
    Cyranoski, David
    NATURE, 2015, 520 (7549) : 594 - 594
  • [28] Current Advancements and Limitations of Gene Editing in Orphan Crops
    Venezia, Matthew
    Creasey Krainer, Kate M.
    FRONTIERS IN PLANT SCIENCE, 2021, 12
  • [29] Progress and Challenges in the Improvement of Ornamental Plants by Genome Editing
    Ahn, Chang Ho
    Ramya, Mummadireddy
    An, Hye Ryun
    Park, Pil Man
    Kim, Yae-Jin
    Lee, Su Young
    Jang, Seonghoe
    PLANTS-BASEL, 2020, 9 (06):
  • [30] Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing (vol 134, pg 117, 2021)
    Domm, Jakob M.
    Wootton, Sarah K.
    Medin, Jeffrey A.
    West, Michael L.
    MOLECULAR GENETICS AND METABOLISM, 2023, 139 (01)